1 - 16 of 16

Amanda M. Ackermann, MD, PhD

Amanda M. Ackermann

Dr. Ackermann studies diabetes (types 1 and 2) and congenital hyperinsulinism using mouse models, cell lines, and primary human tissue. She aims to identify novel pathways regulating beta cell insulin secretion, leading to innovative therapeutic strategies for these disorders. Current studies include in vivo mouse physiology, ex vivo human islet physiology, CRISPR-Cas9 gene editing, epigenetic modification, and single-cell functional genomics.


Peter C. Adamson, MD

Peter C. Adamson

Dr. Adamson serves as chair of the international consortium Children's Oncology Group and on the National Cancer Advisory Board. In addition to his national and international leadership roles in pediatric oncology, Dr. Adamson maintains a dynamic research program on pediatric clinical-translational drug development, with a strong focus on childhood cancer drug development.


Olufunke Afolabi-Brown, MBBS

Olufunke Afolabi-Brown

Dr. Afolabi-Brown's research centers on determining the role of polysomnography in facilitating tracheostomy decannulation in children.


Rebecca C. Ahrens-Nicklas, MD, PhD

Rebecca C. Ahrens-Nicklas, MD, PhD

Dr. Ahrens-Nicklas works to understand why patients with inherited biochemical disorders often suffer severe, untreatable neurologic and cardiac symptoms. She strives to elucidate the link between biochemistry and network excitability, in order to drive new approaches to therapy.


Aletha Akers, MD, MPH

Aletha Akers

Dr. Akers is an adolescent gynecologist and her research focuses on improving reproductive health outcomes among adolescent women by reducing teen pregnancy, and reducing sexually transmitted infection rates by increasing adolescents’ access to high quality reproductive health services.


Julian L. Allen, MD

Julian L. Allen

The research interests of Dr. Allen include lung function testing in children, adolescents, and infants; developmental chest wall physiology; pulmonary complications of sickle cell disease; and complications of cystic fibrosis.


Sandra Amaral, MD, MHS

Sandra Amaral

Dr. Amaral's research is focused on kidney transplantation with particular interests in reducing treatment burden for adolescents and young adults — from designing studies to make daily medication regimens easier to diagnosing transplant injury earlier using innovative, noninvasive approaches.


Richard Aplenc, MD, PhD, MSCE

Richard Aplenc

Dr. Aplenc investigates ways to improve the outcomes of children with cancer, particularly acute myeloid leukemia, with clinical epidemiology studies and translational research.


Kristy B. Arbogast, PhD

Kristy B. Arbogast

As a bioengineer, Dr. Arbogast's research focuses on pediatric injury biomechanics, injury causation and the effectiveness of safety products for children with a concentration in the safety of children and youth in motor vehicle crashes as well as pediatric concussion.


Valder R. Arruda, MD, PhD

Valder R. Arruda

The development of gene-based strategies for the treatment of bleeding and thrombotic diseases is at the heart of research by Dr. Arruda. Working collaboratively, Dr. Arruda and his colleagues have carried out early-phase clinical studies on adeno-associated viral vectors for the treatment of severe hemophilia B.